SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Yvonne Genzel, Thomas Vogel, Johannes Buck, Ilona Behrendt, Daniel Vazquez Ramirez, Gudrun Schiedner, Ingo Jordan, Udo Reichl, High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells, Vaccine, 2014, 32, 24, 2770

    CrossRef

  2. 2
    Marie-Françoise Clincke, Carin Mölleryd, Puneeth K Samani, Eva Lindskog, Eric Fäldt, Kieron Walsh, Véronique Chotteau, Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE bioreactor™—part II: Applications for antibody production and cryopreservation, Biotechnology Progress, 2013, 29, 3
  3. 3
    Marie-Françoise Clincke, Carin Mölleryd, Ye Zhang, Eva Lindskog, Kieron Walsh, Véronique Chotteau, Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor™. Part I. Effect of the cell density on the process, Biotechnology Progress, 2013, 29, 3
  4. 4
    J. Gálvez, M. Lecina, C. Solà, J.J. Cairó, F. Gòdia, Optimization of HEK-293S cell cultures for the production of adenoviral vectors in bioreactors using on-line OUR measurements, Journal of Biotechnology, 2012, 157, 1, 214

    CrossRef

  5. 5
    Allen Chen, Swan Li Poh, Christian Dietzsch, Elisabeth Roethl, Mylene L Yan, Say Kong Ng, Serum-free microcarrier based production of replication deficient Influenza vaccine candidate virus lacking NS1 using Vero cells, BMC Biotechnology, 2011, 11, 1, 81

    CrossRef

  6. 6
    E. Dormond, M. Perrier, A. Kamen, From the first to the third generation adenoviral vector: What parameters are governing the production yield?, Biotechnology Advances, 2009, 27, 2, 133

    CrossRef

  7. 7
    Kalbinder Singh Sandhu, Mohamed Al-Rubeai, The effect of Bcl-2, YAMA, and XIAP over-expression on apoptosis and adenovirus production in HEK293 cell line, Biotechnology and Bioengineering, 2009, 104, 4
  8. 8
    Inn H. Yuk, Gina B. Lin, Hui Ju, Inesse Sifi, Yvonne Lam, Armida Cortez, Danny Liebertz, J. Michael Berry, Richard M. Schwartz, A serum-free Vero production platform for a chimeric virus vaccine candidate, Cytotechnology, 2006, 51, 3, 183

    CrossRef

  9. 9
    James N. Warnock, Otto-Wilhelm Merten, Mohamed Al-Rubeai, Cell Culture Processes for the Production of Viral Vectors for Gene Therapy Purposes, Cytotechnology, 2006, 50, 1-3, 141

    CrossRef

  10. 10
    Monika Lusky, Good Manufacturing Practice Production of Adenoviral Vectors for Clinical Trials, Human Gene Therapy, 2005, 16, 3, 281

    CrossRef

  11. 11
    Nicole A. Bleckwenn, Hana Golding, William E. Bentley, Joseph Shiloach, Production of recombinant proteins by vaccinia virus in a microcarrier based mammalian cell perfusion bioreactor, Biotechnology and Bioengineering, 2005, 90, 6
  12. 12
    Stéphane Carlier, Ioannis A. Kakadiaris, Nabil Dib, Manolis Vavuranakis, Sean M. O’Malley, Khawar Gul, Craig J. Hartley, Ralph Metcalfe, Roxana Mehran, Christodoulos Stefanadis, Erling Falk, Gregg Stone, Martin Leon, Morteza Naghavi, Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques, Current Atherosclerosis Reports, 2005, 7, 2, 164

    CrossRef

  13. 13
    Wei Wen Su, Bioreactors, Perfusion, Encyclopedia of Industrial Biotechnology,